Fundamental Analysis
28 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -93.4% | +69.5% | 2 / 3 | -35.3% | -6.84 pp | -2.54 pp | +2.8% | 0.85 | 16.49 | 179 | −35,3% | 0,7 | −91,0% | 16.49 | 9.97 | +65,4% |
| Pts | 0 | 12 | 8 | 0 | 0 | 0 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 7.600 (close price on 2026-10-19)EPS (TTM): 460,8
Financial charts
1.Revenue & growth
VND bn179Q2/26
1.Revenue & growth
VND bn179Q2/26
2.Profit & growth
VND bn0,74Q2/26
3.Profit mix (Penman)
VND bn17,9Q2/26
4.Margins & cost structure
%12.2%Q2/26
5.Returns & cash cycle
% · days1.7%Q2/26
6.Earnings quality & cash
VND bn-43,7Q2/26
7.Asset structure
VND bn1.805Q2/26
8.Funding & debt health
VND bn · times1.805Q2/26
9.Revenue backlog
VND bn422Q2/26
10.Valuation
times · %22,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %18Q2/26
Adjusted EPS growth, latest quarter
-93.4%
Average adjusted EPS growth, 3 quarters
-93.4%
averaged over 1 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
37.7%
Source: vnstockData through Q2/26